Status:
UNKNOWN
Covid-19 and Diabetes in West of Algeria
Lead Sponsor:
Laboratoire De Recherche Sur Le Diabete, Université de Tlemcen
Collaborating Sponsors:
ATRSS, DGRST, Algeria
Conditions:
Coronavirus Infections
Diabetes Mellitus
Eligibility:
All Genders
16+ years
Brief Summary
By Jan 7, 2020, Chinese scientists had isolated a novel coronavirus, from patients with virus-infected pneumonia. The WHO designated later this virus as COVID-19 (coronavirus disease 2019). This expon...
Eligibility Criteria
Inclusion
- Patients admitted in a hospital center since 1th April 2020
- Patients with COVID19 with biological proof (specific PCR) or with clinical and radiological diagnosis.
- Patient with diabetes known before the admission
- New onset diabetes discovered at admission (plasma glycaemia value strictly greater than 2 g/l at any time)
Exclusion
- Pregnant
- Active Cancer
- Dementia
- Minors, adults under guardianship, protected persons
- Significant disability (The Modified Rankin Scale more than 2 prior admission)
Key Trial Info
Start Date :
April 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2020
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04412746
Start Date
April 1 2020
End Date
June 30 2020
Last Update
June 2 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Internal Medicine, Acedemic Hospital of Tlemcen
Tlemcen, Algeria, 130000